On August 3, 2017, the Senate voted overwhelmingly in favor of the House-passed FDA Reauthorization Act, which will reauthorize the FDA's user fee agreements. These agreements provide funding for the FDA to promptly review and approve new drugs and devices and accelerate the pace of biomedical innovation. Thank Congress for passing this important legislation today.
